Table 2. Human HLA class II restricted epitopes against pathogenic arenaviruses.
Epitope | Peptide Sequence | MHC II Restriction | Reference(s) |
LASV | |||
GPC236–250 | PSPIGYLGLLSQRTR | HLA-DRB1*0101 | [78] |
GPC241–255 | YLGLLSQRTRDIYIS | HLA-DRB1*0101 | [78] |
GPC282–294 | RWMLIEAELKCFG | HLA-DRB | [31] |
GPC289–301 | ELKCFGNTAVAKC | HLA-DRB | [31] |
GPC394–406 | LNETHFSDDIEQQ | HLA-DRB | [31] |
GPC476–490 | SCGLYKQPGVPVRWK | HLA-DRB1*0101 | [78] |
NP176–188 | FGTMPSLTLACLT | HLA-DRB | [79] |
NP190–202 | QGQVDLNDAVQAL | HLA-DRB | [79] |
NP288–300 | ALGMFISDTPGER | HLA-DRB | [79] |
NP379–391 | QLDPNAKTWMDIE | HLA-DRB | [79] |
NP498–510 | VWDQYKDLCHMHT | HLA-DRB | [79] |
GTOV | |||
GPC131–145 | KGSPEFDWILGWTIK | HLA-DRB1*0101 | [78] |
L181–195 | DQEYHRLIHSLSKTS | HLA-DRB1*0101 | [78] |
L391–405 | RVLDILVARRLLLKK | HLA-DRB1*0101 | [78] |
L1826–1840 | IQLVFSSMINPLVIT | HLA-DRB1*0101 | [78] |
NP166–180 | KLNNQFGSMPALTIA | HLA-DRB1*0101 | [78] |
NP191–205 | NNVVQALTSLGLLYT | HLA-DRB1*0101 | [78] |
NP236–250 | ISGYNFSLSAAVKAG | HLA-DRB1*0101 | [78] |
NP541–555 | IPIQLLPNTLVFQAK | HLA-DRB1*0101 | [78] |
JUNV | |||
GPC46–60 | FFVFLALAGRSCTEE | HLA-DRB1*0101 | [78] |
L381–395 | VGQMLMLVNDRLLDI | HLA-DRB1*0101 | [78] |
L391–405 | RLLDILEAIKLIRKK | HLA-DRB1*0101 | [78] |
L411–425 | KWVQMCSRTLKNSHQ | HLA-DRB1*0101 | [78] |
L1491–1505 | MFIRNCARKVFNDIK | HLA-DRB1*0101 | [78] |
L1711–1725 | NKNFFWAVKPKAVRQ | HLA-DRB1*0101 | [78] |
LCMV | |||
GPC66–80 | DIYKGVYQFKSVEFD | *0701 | [77] |
GPC71–85 | VYQFKSVEFDMSHLN | *0701 | [77] |
GPC341–355 | HLFKTTVNSLISDQL | *0701 | [77] |
GPC421–435 | LRKDYIKRQGSTPLA | HLA-DRB1*0101 | [78] |
L256–270 | RNFQKVNPEGLIKEF | HLA-DRB1*0101 | [78] |
L946–960 | HLRKVILSEISFHLV | HLA-DRB1*0101 | [78] |
NP6–20 | EVKSFQWTQALRREL | HLA-DRB1*0101 | [78] |
NP86–100 | KNVLKVGRLSAEELM | *1101 | [77] |
NP106–120 | LEKLKAKIMRSERPQ | *0801 | [77] |
NP236–250 | NISGYNFSLGAAVKA | *0701 | [77] |
NP261–275 | LESILIKPSNSEDLL | *0701 | [77] |
NP281–295 | AKRKLNMFVSDQVGD | *0701 | [77] |
NP311–325 | EGWPYIACRTSIVGR | *0701 | [77] |
NP356–370 | VGLSYSQTMLLKDLM | *0701 | [77] |
NP411–425 | VDQKQFKQDSKYSHG | *0701 | [77] |
NP521–535 | MDCIIFESASKARLP | HLA-DRB1*0101, *0801 | [77], [78] |
MACV | |||
GPC96–110 | NSFYYMKGGVNTFLI | HLA-DRB1*0101 | [78] |
GPC251–265 | SKTHLNFERSLKAFF | HLA-DRB1*0101 | [78] |
GPC446–460 | ASLFLHLVGIPTHRH | HLA-DRB1*0101 | [78] |
L391–405 | DRVLDILEAVKLIRK | HLA-DRB1*0101 | [78] |
L636–650 | RYFLMAFANQIHHID | HLA-DRB1*0101 | [78] |
L866–880 | DYLILKNLTGLVSAG | HLA-DRB1*0101 | [78] |
L1491–1505 | TSFIRNCARKVFNDI | HLA-DRB1*0101 | [78] |
L1711–1725 | NNQNFFWAVKPKVVR | HLA-DRB1*0101 | [78] |
NP191–205 | NSVVQALTSLGLLYT | HLA-DRB1*0101 | [78] |
Z21–35 | PSAEFRRTAPPSLYG | HLA-DRB1*0101 | [78] |
Italics, predicted restriction only. GTOV, Guanarito virus; JUNV, Junin virus; LASV, Lassa virus; LCMV, lymphocytic choriomeningitis virus; MACV, Machupo virus.